Hemostasis, Surgical

• 

  Subject Areas on Research

  • A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. 
  • An endoluminal method of hemorrhage control and repair of ruptured abdominal aortic aneurysms. 
  • Application of energy-based technologies and topical hemostatic agents in the management of surgical hemostasis. 
  • Bedside Tracheostomy on Pediatric ICU Subjects Supported by Extracorporeal Membrane Oxygenation. 
  • Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonists. 
  • Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery. 
  • Bivalirudin: a review of the pharmacology and clinical application. 
  • Bovine thrombin: history, use, and risk in the surgical patient. 
  • Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. 
  • Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis. 
  • Ectopic pregnancy: role of laparoscopic treatment. 
  • Evaluation and Comparison of Contemporary Energy-Based Surgical Vessel Sealing Devices. 
  • Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. 
  • Fatal and nonfatal hemorrhagic complications of living kidney donation. 
  • Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. 
  • Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. 
  • Hand-assisted laparoscopic partial nephrectomy without hilar vascular clamping using a saline-cooled, high-density monopolar radiofrequency device. 
  • Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. 
  • Hemostatic agent and concomitant abdominal abscess. 
  • Heterotopic cervical pregnancy treated with transvaginal ultrasound-guided aspiration resulting in cervical site varices within the myometrium. 
  • Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. 
  • International normalized ratio. 
  • Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. 
  • Invited letter concerning: the promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis and postoperative mediastinitis--a comparison of two electrocautery techniques on presternal soft tissues. 
  • Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR). 
  • Management of surgical hemostasis: systemic agents. 
  • Management of surgical hemostasis: topical agents. 
  • New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. 
  • Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. 
  • Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry. 
  • Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications. 
  • PlasmaKinetic bipolar vessel sealing: burst pressures and thermal spread in an animal model. 
  • Prohemostatic agents to prevent perioperative blood loss. 
  • Prohemostatic treatment in cardiac surgery. 
  • Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature. 
  • Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry. 
  • Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. 
  • Recent clinical and investigational applications of fibrin sealant in selected surgical specialties. 
  • Recombinant activated factor VII and the anaesthetist. 
  • Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. 
  • Reductions in blood loss with a bipolar sealer in total hip arthroplasty. 
  • Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. 
  • Relative purity of thrombin-based hemostatic agents used in surgery. 
  • Review of the biology of bleeding and clotting in the surgical patient. 
  • Simplified hemostatic technique during laparoscopic partial nephrectomy. 
  • Transradial coronary stenting: comparison with femoral access closed with an arterial suture device. 
  • What is the evidence for platelet transfusion in perioperative settings? 
  • Wound hematoma: prophylaxis with topical thrombin. 
• 

  Keywords of People

  • Hoffman, Maureane Richardson, Professor of Pathology, Immunology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Professor of Urology, Surgery